Carcinogenesis, Vol. 22, No. 10, 1615-1623,
October 2001
© 2001 Oxford University Press
CANCER BIOLOGY |
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
1 Laboratory for Cancer Research, College of Pharmacy, Rutgers–The State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854-8020, USA and
2 Henan Medical University, Zhengzhou, Henan 457500, China
The three human leukocyte antigen (HLA) class I antigens, HLA-A, HLA-B and HLA-C, play important roles in the elimination of transformed cells by cytotoxic T cells. Frequent loss of expression of these antigens at the cell surface has been observed in many human cancers. Various mechanisms for post-transcriptional regulation have been proposed and tested but the molecular mechanisms for transcriptional regulation are not clear. We show by immunohistochemistry that the HLA class I antigens are absent in 26 of 29 (89%) samples of human esophageal squamous cell carcinomas (ESCC). Eleven of the 26 ESCC samples lost mRNA expression for at least one of the HLA genes, as shown by RT–PCR. DNA from the 29 pairs of ESCC and neighboring normal epithelium were examined for CpG island hypermethylation, homozygous deletion, microsatellite instability (MSI) and loss of heterozygosity (LOH). DNA from normal epithelial tissues had no detectable methylation of the CpG islands of any of these gene loci. Thirteen of 29 ESCC samples (45%) exhibited methylation of one or more of the three HLA loci and six samples (21%) exhibited methylation of all three loci. The HLA-B gene locus was most frequently methylated (38%). HLA-B mRNA expression in an ESCC cell line, where HLA-B was hypermethylated and did not express mRNA, was activated after treatment with 5-aza-2'-deoxycytidine. Homozygous deletion of these three gene loci was not observed. Relatively low rates of LOH and MSI were observed for the microsatellite markers D6S306, D6S258, D6S273 and D6S1666, close to the HLA-A, -B and -C loci, although a high ratio of LOH was observed at a nearby locus (represented by the markers D6S1051 and D6S1560), where the tumor suppressor gene p21Waf1 resides. A strong correlation between genetic alterations and mRNA inactivation was observed in the ESCC samples. Our results indicate that HLA class I gene expression was frequently down-regulated in ESCC at both the protein and mRNA levels and that hypermethylation of the promoter regions of the HLA-A, -B and -C genes is a major mechanism of transcriptional inactivation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. S. Kim, K. Yamashita, Y. K. Chae, Y. Tokumaru, X. Chang, M. Zahurak, M. Osada, H. L. Park, A. Chuang, J. A. Califano, et al. A Promoter Methylation Pattern in the N-Methyl-D-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 15, 2007; 13(22): 6658 - 6665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buness, R. Kuner, M. Ruschhaupt, A. Poustka, H. Sultmann, and A. Tresch Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer Bioinformatics, September 1, 2007; 23(17): 2273 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Clark Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis Hum. Mol. Genet., April 15, 2007; 16(R1): R88 - R95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Rajendra, R Ackroyd, N Karim, C Mohan, J J Ho, and M K Kutty Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus J. Clin. Pathol., September 1, 2006; 59(9): 952 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kim, K. Yamashita, J. H. Baek, H. L. Park, A. L. Carvalho, M. Osada, M. O. Hoque, S. Upadhyay, M. Mori, C. Moon, et al. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res., April 1, 2006; 66(7): 3409 - 3418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ryschich, T. Notzel, U. Hinz, F. Autschbach, J. Ferguson, I. Simon, J. Weitz, B. Frohlich, E. Klar, M. W. Buchler, et al. Control of T-Cell-Mediated Immune Response by HLA Class I in Human Pancreatic Carcinoma Clin. Cancer Res., January 15, 2005; 11(2): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Fang, C. Liu, Y. Song, G.-Y. Yang, Y. Nie, J. Liao, X. Zhao, Y. Shimada, L.-D. Wang, and C. S. Yang Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas Carcinogenesis, June 1, 2004; 25(6): 865 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Hsiao, K.-W. Liao, S.-W. Hung, and R.-M. Chu Tumor-Infiltrating Lymphocyte Secretion of IL-6 Antagonizes Tumor-Derived TGF-{beta}1 and Restores the Lymphokine-Activated Killing Activity J. Immunol., February 1, 2004; 172(3): 1508 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Karpf, A. W. Lasek, T. O. Ririe, A. N. Hanks, D. Grossman, and D. A. Jones Limited Gene Activation in Tumor and Normal Epithelial Cells Treated with the DNA Methyltransferase Inhibitor 5-Aza-2'-deoxycytidine Mol. Pharmacol., January 1, 2004; 65(1): 18 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, M. Z. Fang, J. Liao, G.-Y. Yang, Y. Nie, Y. Song, C. So, X. Xu, L.-D. Wang, and C. S. Yang Hypermethylation-Associated Inactivation of Retinoic Acid Receptor {beta} in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2003; 9(14): 5257 - 5263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kanaseki, H. Ikeda, Y. Takamura, M. Toyota, Y. Hirohashi, T. Tokino, T. Himi, and N. Sato Histone Deacetylation, But Not Hypermethylation, Modifies Class II Transactivator and MHC Class II Gene Expression in Squamous Cell Carcinomas J. Immunol., May 15, 2003; 170(10): 4980 - 4985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nie, J. Liao, X. Zhao, Y. Song, G.-y. Yang, L.-D. Wang, and C. S. Yang Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma Carcinogenesis, October 1, 2002; 23(10): 1713 - 1720. [Abstract] [Full Text] [PDF]
|
|